The Bull Rankings scorecard — our quality-growth score is 26.4 / 100, built from three pillars scored 0–100: Quality 17, Growth 98, Value 11 (valuation is judged against sector peers).
The thesis
Rocket Lab’s current price of $62.95 gives it a $40.3 b market cap, well below the $111 consensus target of 18 analysts. The Bull Rankings model gives RKLB a 26.4/100 quality‑growth score. Growth is the star at 98, while value lags at 11. That tells us the market is pricing in a very high‑growth story but not a bargain. The three pillars together paint a picture: the company is growing fast, but its valuation is stretched. The thesis is simple: RKLB’s case rests on turning on its free‑cash‑flow engine fast enough to justify a valuation that already assumes years of success.
Three figures back this stance. First, revenue jumped 52.5% YoY in FY 2026, a rapid growth rate. Second, the P/S of 52.3 is high, but the company’s free‑cash‑flow is still negative at -$371 m—a sign that the price is not yet fully discounted for the cash‑flow gap. Third, the beta of 2.61 means the stock swings far more than the market.
What the business actually is
Rocket Lab sells launch services and space‑systems solutions across the United States, Canada, Japan, and globally. Its revenue engine is split into two segments: launch services and space systems. The launch arm delivers the Electron small‑launch vehicle, a dedicated platform for small‑satellite customers. The space‑systems arm offers spacecraft design, manufacturing, optical systems, and on‑orbit management, including constellation‑management services. It is also developing Neutron, a larger reusable rocket meant to compete for medium‑lift missions. These segments together fuel the company’s rapid top‑line growth.
Why it can (or can't) keep compounding
The durability case hinges on the Electron platform’s niche. Electron is a small‑class rocket designed for small payloads. The company’s debt‑to‑equity of 0.04 shows a clean balance sheet, giving it room to invest in capacity without borrowing. However, margins are -21.5%, and free‑cash‑flow remains negative, signaling that the business is still in a heavy‑investment phase. The model’s “Diluting shareholders” signal shows heavy stock issuance has already shrunk each holder’s stake. Competitors like SpaceX or Blue Origin can copy the small‑launch concept, but Rocket Lab’s established Electron supply chain and customer relationships create a modest moat that will take time to erode.
The valuation question
Our reverse DCF has no read here, so the anchor is the 52.5% YoY revenue growth. The growth pillar at 98 reflects that pace, but the current P/S of 52.3 implies a revenue multiple far above the sector median. The free‑cash‑flow deficit of -$371 m means the DCF fair value would be lower unless the company turns profitable. In other words, the market is pricing in optimism: it is paying for years of rapid growth and a closing cash‑flow gap. If that growth stalls, the stock is overvalued; if it holds and losses narrow, the upside is significant.
The bear case
The most compelling skeptic points to the negative free‑cash‑flow of -$371 m. A company that cannot generate cash from operations is a red flag, especially in a capital‑intensive industry. If Rocket Lab fails to convert its revenue growth into positive cash flow within the next 12–18 months, more dilution is likely, and the price could retreat. The 52‑week low of $37.57 shows how far the stock has fallen before.
What would change our mind
- Free‑cash‑flow turns positive: If RKLB reports a positive FCF in the next quarter, the valuation gap narrows.
- Revenue growth slows below 30%: A drop below the current 52.5% would weaken the growth pillar and push the price down.
- Debt‑to‑equity rises above 0.1: Any significant increase would signal financial strain and erode the clean balance‑sheet advantage.
If any of these thresholds are breached, the thesis would shift from speculative growth to caution.